#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small cell lung cancer recurrent Hyperinsulinism Biliary neoplasm Rhabdomyosarcoma recurrent Scedosporium infection T-cell type acute leukaemia Acute myeloid leukaemia recurrent Fibrodysplasia ossificans progressiva Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Mycobacterium abscessus infection Hypochondroplasia Leiomyosarcoma recurrent Sickle cell anaemia Glomerulonephritis membranous Follicular lymphoma stage II More trials…

    Learn about Rare Diseases

    Langerhans cell sarcoma – Life with Disease Primary mediastinal large B-cell lymphoma – Trials in Disease Netherton’s syndrome – Treatment Synovial sarcoma metastatic – Basic Information Propionic acidaemia – Trials in Disease Ornithine transcarbamoylase deficiency – Life with Disease Breast angiosarcoma metastatic – Basic Information Congenital hypotransferrinaemia Cystic fibrosis – Basic Information Haemophilia B with anti factor IX – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Infliximab Cobamamide Elasomeran R3R01 Sitravatinib Malate Ciprofloxacin 4-IODOPHENYLALANINE I-131 Suvecaltamide Omp64 Oms906 Glucose Monohydrate Ph. Eur. Streptococcus Pneumoniae Clindamycin Phosphate Fingolimod Censavudine Fazirsiran Lamotrigine Hhalpc Piperacillin SECRETIN SYNTHETIC HUMAN More therapies…

    Learn about Your Condition

    Tachypnoea Optic atrophy Gender dysphoria Testicular germ cell cancer Epicondylitis Pharyngeal cancer stage II Fibrous dysplasia of bone B-cell lymphoma recurrent Acute on chronic liver failure Lymphocytic leukaemia Agitation Noonan syndrome Ophthalmoplegia Bacteraemia Brain abscess More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of KK8123 for Adults with X-linked Hypophosphatemia

    Recruiting

    1 1 1
    Investigated Drugs:
    • Kk8123
    France Germany Spain

  • Study on the Effectiveness and Safety of IgM-Enriched Immunoglobulin Therapy for Patients with Septic Shock

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Immunoglobulin A
    • Immunoglobulin G
    • Immunoglobulin M
    Italy

  • Study on the Safety of VO659 for Patients with Spinocerebellar Ataxia Types 1, 3, and Huntington’s Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hereditary ataxia
    • Huntington’s disease
    Investigated Drugs:
    • Vo659
    Denmark France Germany The Netherlands

  • Study of BOLD-100 with FOLFOX chemotherapy (fluorouracil, folinic acid, and oxaliplatin) in patients with advanced gastrointestinal tumors, colorectal, gastric, or pancreatic cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Sodium Trans-[Tetrachlorobis(1H-Indazole)Ruthenate(Iii) Dihydrate
    • Fluorouracil
    • Folinic Acid
    Germany Ireland Italy Spain

  • Study on the Effects of Sodium Lactate and Saline Solutions in Patients with Septic Shock

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Sodium Lactate
    Czechia

  • Study on Metformin Embonate to Slow Growth of Small Abdominal Aortic Aneurysms in Patients Without Diabetes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Aortic aneurysm
    Investigated Drugs:
    • Metformin Embonate
    Denmark The Netherlands Sweden
Previous Page
1 … 412 413 414 415 416 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!